US Patent 11174256 Imidazopyridine derivatives
Patent 11174256 was granted and assigned to Gilead Sciences on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+73 characters)
Article
Patent abstract
The present disclosure provides a compound of Formula (I):
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111742560
Date of Patent
November 16, 2021
0Patent Application Number
166675320
Date Filed
October 29, 2019
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 15 Feb, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111742560
Date of Patent
November 16, 2021
0Patent Application Number
166675320
Date Filed
October 29, 2019
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11174256 Imidazopyridine derivatives
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11174256
Date of patent
November 16, 2021
Patent application number
16667532
Date Filed
October 29, 2019
Patent primary examiner
Find more entities like US Patent 11174256 Imidazopyridine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
